These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32999203)

  • 21. Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors.
    Makimoto A; Fang J; Maeda H
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.
    Tsukigawa K; Liao L; Nakamura H; Fang J; Greish K; Otagiri M; Maeda H
    Cancer Sci; 2015 Mar; 106(3):270-8. PubMed ID: 25529761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved Tumor-Specific Drug Accumulation by Polymer Therapeutics with pH-Sensitive Drug Release Overcomes Chemotherapy Resistance.
    Heinrich AK; Lucas H; Schindler L; Chytil P; Etrych T; Mäder K; Mueller T
    Mol Cancer Ther; 2016 May; 15(5):998-1007. PubMed ID: 26939698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPMA copolymer conjugated 5-aminolevulinic acid exhibits superior efficacy for photodynamic therapy with tumor-responsive and targeting properties.
    Islam R; Kotalík K; Šubr V; Gao S; Zhou JR; Yokomizo K; Etrych T; Fang J
    Nanomedicine; 2023 Feb; 48():102636. PubMed ID: 36549553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the pharmacological and biological properties of HPMA copolymer-pirarubicin conjugates: A single-chain copolymer conjugate and its biodegradable tandem-diblock copolymer conjugate.
    Etrych T; Tsukigawa K; Nakamura H; Chytil P; Fang J; Ulbrich K; Otagiri M; Maeda H
    Eur J Pharm Sci; 2017 Aug; 106():10-19. PubMed ID: 28528285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acid-responsive HPMA copolymer-bradykinin conjugate enhances tumor-targeted delivery of nanomedicine.
    Appiah E; Nakamura H; Pola R; Grossmanová E; Lidický O; Kuniyasu A; Etrych T; Haratake M
    J Control Release; 2021 Sep; 337():546-556. PubMed ID: 34375687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study.
    Kudláčová J; Kotrchová L; Kostka L; Randárová E; Filipová M; Janoušková O; Fang J; Etrych T
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33419291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy.
    Xiang Y; Chen L; Zhou R; Huang Y
    Int J Pharm; 2019 Oct; 570():118668. PubMed ID: 31494237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging.
    Etrych T; Daumová L; Pokorná E; Tušková D; Lidický O; Kolářová V; Pankrác J; Šefc L; Chytil P; Klener P
    J Control Release; 2018 Nov; 289():44-55. PubMed ID: 30248447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies.
    Yanazume S; Fang J; Islam R; Gao S; Kobayashi H
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
    Li L; Yang Q; Zhou Z; Zhong J; Huang Y
    Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanotherapeutics with suitable properties for advanced anticancer therapy based on HPMA copolymer-bound ritonavir via pH-sensitive spacers.
    Machová D; Koziolová E; Chytil P; Venclíková K; Etrych T; Janoušková O
    Eur J Pharm Biopharm; 2018 Oct; 131():141-150. PubMed ID: 30075311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes.
    Kinoshita R; Ishima Y; Ikeda M; Kragh-Hansen U; Fang J; Nakamura H; Chuang VT; Tanaka R; Maeda H; Kodama A; Watanabe H; Maeda H; Otagiri M; Maruyama T
    J Control Release; 2015 Nov; 217():1-9. PubMed ID: 26302904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodegradable Micellar HPMA-Based Polymer-Drug Conjugates with Betulinic Acid for Passive Tumor Targeting.
    Lomkova EA; Chytil P; Janoušková O; Mueller T; Lucas H; Filippov SK; Trhlíková O; Aleshunin PA; Skorik YA; Ulbrich K; Etrych T
    Biomacromolecules; 2016 Nov; 17(11):3493-3507. PubMed ID: 27636143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative and Injectable Preformed Albumin-Bound Anticancer Drug Delivery System for Anticancer and Antimetastasis Treatment.
    Zhou C; Song X; Guo C; Tan Y; Zhao J; Yang Q; Chen D; Tan T; Sun X; Gong T; Zhang Z
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):42534-42548. PubMed ID: 31479235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of the Enhanced Permeability and Retention Effect with Nitric Oxide-Generating Agents Improves the Therapeutic Effects of Nanomedicines.
    Islam W; Fang J; Imamura T; Etrych T; Subr V; Ulbrich K; Maeda H
    Mol Cancer Ther; 2018 Dec; 17(12):2643-2653. PubMed ID: 30232144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymer donors of nitric oxide improve the treatment of experimental solid tumours with nanosized polymer therapeutics.
    Šírová M; Horková V; Etrych T; Chytil P; Říhová B; Studenovský M
    J Drug Target; 2017; 25(9-10):796-808. PubMed ID: 28726521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
    Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
    J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors.
    Koziolová E; Janoušková O; Cuchalová L; Hvězdová Z; Hraběta J; Eckschlager T; Sivák L; Ulbrich K; Etrych T; Šubr V
    J Control Release; 2016 Jul; 233():136-46. PubMed ID: 27189135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.